Biomarker Deals and Alliances of 2014

 Published On: Mar, 2015 |    No of Pages: 200 |  Published By: CurrentPartnering | Format: PDF
Request Free Sample   Share on Whatsapp
The Biomarker Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014.

Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide.
The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities.

Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication.

Chapter 2 provides a comprehensive listing of leading deals by deal values, most active dealmakers, big pharma and big biotech deal activity.

Chapter 3 provides a comprehensive listing of leading deals of 2014 listed by big pharma company profiles, as well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Chapter 4 provides a comprehensive listing of leading deals of 2014 listed by big biotech company profiles, as well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Chapter 5 provides a comprehensive directory of all partnering deals announced during 2014.
The chapter is organized by company A-Z, deal type (collaborative R&D, co-promotion, licensing etc), therapy area and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in partnering and dealmaking during 2014.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products during 2014.
Biomarker Deals and Alliances of 2014 provides the reader with the following key benefits:

In-depth understanding of recent biomarker dealmaking trends during 2014
Comprehensive access to all biomarker deals entered into by the world’s biopharma companies during 2014
Detailed access to actual partnership deals and contracts entered into by the leading fifty big pharma and big biotech companies
Understand the key deal terms companies have agreed in previous deals
Full listing of biomarker deals by company A-Z, deal type, technology and therapy focus
Identify leading biomarker deals by value during 2014
Identify the most active biomarker dealmakers during 2014
Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Report scope

Biomarker Deals and Alliances of 2014 is intended to provide the reader with an in-depth understanding and access to parthering trends and structure of deals entered into by leading companies worldwide.

Biomarker Deals and Alliances of 2014includes:

Trends in dealmaking in the biopharma industry during 2014
Comprehensive directory of partnering deals in 2014
Links to online access to all deals and alliances
The leading partnering deals by value in 2014
Most active partnering dealmakers during 2014

In Biomarker Deals and Alliances of 2014 the partnering deals are listed by:

Company A-Z
Headline value
Stage of development at signing
Deal component type
Therapy area
Technology type

Each deal title links via Weblink to an online version of the deal record at Current Agreements and where available, the contract document, providing easy access to each contract document on demand.
Executive Summary

Introduction

Chapter 1 – Trends in dealmaking during 2014

1.1 Introduction
1.2. Partnering by deal type
1.3. Partnering by industry sector
1.4. Partnering by stage of development
1.5. Partnering by technology type
1.6. Partnering by therapy area

Chapter 2 – Leading deals during 2014

2.1. Introduction
2.2 Most active partnering in 2014
2.3. Top deals by value during 2014
2.4. Big pharma dealmaking activity
2.5. Big biotech dealmaking activity

Chapter 3 – Big pharma deals during 2014

3.1. Introduction
3.2. How to use big pharma partnering deals
3.3. Big pharmapartnering company profiles

Chapter 4 – Big biotech deals during 2014

4.1. Introduction
4.2. How to use big biotech partnering deals
4.3. Big biotech partnering company profiles

Chapter 5 – Partnering deals directory 2014

5.1. Introduction
5.2. Company A-Z
5.3. By deal type
5.4. By stage of development
5.5. By technology type
5.6. By therapy area

About Wildwood Ventures
Current Partnering
Current Agreements


Table of Figures
Figure 1: Partnering by deal type during 2014
Figure 2: Partnering by industry sector during 2014
Figure 3: Partnering by stage of development during 2014
Figure 4: Partnering by technology type during 2014
Figure 5: Partnering by therapy area during 2014
Figure 6: Active drug delivery dealmaking activity–2014
Figure 7: Top deals by value during 2014
Figure 8: Big pharma – top 50 – January to December 2014
Figure 9: Big pharma deal frequency – 2014
Figure 10: Big biotech – top 50 – January to December 2014
Figure 11: Big biotech deal frequency – 2014

If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.